QuarterlyIQ Insights · CSX
Price
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Price
Daily closes. Earnings/event dots inline.
What it's worth (estimated)
A consensus fair price across 7 valuation methods, at three horizons. Current price $47.28. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Long-thesis check; widest uncertainty.
By method
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Conf. |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $52.50 | 18.0 | 3.45 | TTM | 50 |
| Peer P/FCF | 12M | $16.74 | 27.4 | 0.61 | TTM | 50 |
| Peer P/E | 12M | $44.19 | 26.0 | 1.70 | TTM | 50 |
| Peer P/S | 12M | $27.45 | 3.7 | 7.49 | TTM | 50 |
| PEG | 12M | $79.63 | 46.8 | 1.70 | TTM | 50 |
| Own P/E history | 12M | $33.35 | 19.6 | 1.70 | TTM | 50 |
| triangulated | 12M | $44.57 | 26.0 | 1.71 | Triangulated | 50 |
| Peer P/FCF | 3Y | $5.73 | 27.4 | 0.21 | Hist. CAGR(prov.) | 30 |
| Peer P/E | 3Y | $70.47 | 26.0 | 2.71 | Analyst | 30 |
| Peer P/S | 3Y | $33.55 | 3.7 | 9.16 | Analyst | 30 |
| PEG | 3Y | $126.97 | 46.8 | 2.71 | Analyst | 30 |
| Own P/E history | 3Y | $53.18 | 19.6 | 2.71 | Analyst | 30 |
| Peer P/E | 5Y | $96.18 | 26.0 | 3.70 | Analyst | 48 |
| Peer P/S | 5Y | $38.35 | 3.7 | 10.47 | Analyst | 48 |
| PEG | 5Y | $173.31 | 46.8 | 3.70 | Analyst | 48 |
| Own P/E history | 5Y | $72.58 | 19.6 | 3.70 | Analyst | 48 |
Composite score history
Daily snapshots of the composite. Zero is the dotted line. Above it leans positive.
P/E history
Monthly trailing P/E with quartile reference lines.
Composite score history currently shows a rolling 60-day window. We're extending it back through full coverage and adding a “consensus-then vs. actual-now” overlay (what our valuation estimate said on a past date versus where the price actually landed).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.